111 related articles for article (PubMed ID: 26017621)
1. Inhibition of prostate cancer cell growth by 3',4',5'-trimethoxyflavonol (TMFol).
Hill CU; Saad SE; Britton RG; Gescher AJ; Sale S; Brown K; Howells LM
Cancer Chemother Pharmacol; 2015 Jul; 76(1):179-85. PubMed ID: 26017621
[TBL] [Abstract][Full Text] [Related]
2. Preclinical colorectal cancer chemopreventive efficacy and p53-modulating activity of 3',4',5'-trimethoxyflavonol, a quercetin analogue.
Howells LM; Britton RG; Mazzoletti M; Greaves P; Broggini M; Brown K; Steward WP; Gescher AJ; Sale S
Cancer Prev Res (Phila); 2010 Aug; 3(8):929-39. PubMed ID: 20628003
[TBL] [Abstract][Full Text] [Related]
3. Tissue distribution and metabolism of the putative cancer chemopreventive agent 3',4',5'-trimethoxyflavonol (TMFol) in mice.
Saad SE; Jones DJ; Norris LM; Horner-Glister E; Patel KR; Britton RG; Steward WP; Gescher AJ; Brown K; Sale S
Biomed Chromatogr; 2012 Dec; 26(12):1559-66. PubMed ID: 22454297
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of novel flavonols as potential anti-prostate cancer agents.
Britton RG; Horner-Glister E; Pomenya OA; Smith EE; Denton R; Jenkins PR; Steward WP; Brown K; Gescher A; Sale S
Eur J Med Chem; 2012 Aug; 54():952-8. PubMed ID: 22789812
[TBL] [Abstract][Full Text] [Related]
5. A new class of flavonol-based anti-prostate cancer agents: Design, synthesis, and evaluation in cell models.
Li X; Chen G; Zhang X; Zhang Q; Zheng S; Wang G; Chen QH
Bioorg Med Chem Lett; 2016 Sep; 26(17):4241-5. PubMed ID: 27476422
[TBL] [Abstract][Full Text] [Related]
6. 3-O-Substituted-3',4',5'-trimethoxyflavonols: Synthesis and cell-based evaluation as anti-prostate cancer agents.
Li X; Lee M; Chen G; Zhang Q; Zheng S; Wang G; Chen QH
Bioorg Med Chem; 2017 Sep; 25(17):4768-4777. PubMed ID: 28760528
[TBL] [Abstract][Full Text] [Related]
7. Combination of Quercetin and 2-Methoxyestradiol Enhances Inhibition of Human Prostate Cancer LNCaP and PC-3 Cells Xenograft Tumor Growth.
Yang F; Song L; Wang H; Wang J; Xu Z; Xing N
PLoS One; 2015; 10(5):e0128277. PubMed ID: 26011145
[TBL] [Abstract][Full Text] [Related]
8. Pentagalloylglucose induces autophagy and caspase-independent programmed deaths in human PC-3 and mouse TRAMP-C2 prostate cancer cells.
Hu H; Chai Y; Wang L; Zhang J; Lee HJ; Kim SH; Lü J
Mol Cancer Ther; 2009 Oct; 8(10):2833-43. PubMed ID: 19825802
[TBL] [Abstract][Full Text] [Related]
9. The dietary flavonol fisetin enhances the apoptosis-inducing potential of TRAIL in prostate cancer cells.
Szliszka E; Helewski KJ; Mizgala E; Krol W
Int J Oncol; 2011 Oct; 39(4):771-9. PubMed ID: 21743964
[TBL] [Abstract][Full Text] [Related]
10. Gallic acid, an active constituent of grape seed extract, exhibits anti-proliferative, pro-apoptotic and anti-tumorigenic effects against prostate carcinoma xenograft growth in nude mice.
Kaur M; Velmurugan B; Rajamanickam S; Agarwal R; Agarwal C
Pharm Res; 2009 Sep; 26(9):2133-40. PubMed ID: 19543955
[TBL] [Abstract][Full Text] [Related]
11. Survivin gene silencing sensitizes prostate cancer cells to selenium growth inhibition.
Liu X; Gao R; Dong Y; Gao L; Zhao Y; Zhao L; Zhao X; Zhang H
BMC Cancer; 2010 Aug; 10():418. PubMed ID: 20698994
[TBL] [Abstract][Full Text] [Related]
12. Fisetin Enhances Chemotherapeutic Effect of Cabazitaxel against Human Prostate Cancer Cells.
Mukhtar E; Adhami VM; Siddiqui IA; Verma AK; Mukhtar H
Mol Cancer Ther; 2016 Dec; 15(12):2863-2874. PubMed ID: 27765854
[TBL] [Abstract][Full Text] [Related]
13. Acetyl-L-Carnitine downregulates invasion (CXCR4/CXCL12, MMP-9) and angiogenesis (VEGF, CXCL8) pathways in prostate cancer cells: rationale for prevention and interception strategies.
Baci D; Bruno A; Cascini C; Gallazzi M; Mortara L; Sessa F; Pelosi G; Albini A; Noonan DM
J Exp Clin Cancer Res; 2019 Nov; 38(1):464. PubMed ID: 31718684
[TBL] [Abstract][Full Text] [Related]
14. Iron Induces Cell Death and Strengthens the Efficacy of Antiandrogen Therapy in Prostate Cancer Models.
Bordini J; Morisi F; Elia AR; Santambrogio P; Pagani A; Cucchiara V; Ghia P; Bellone M; Briganti A; Camaschella C; Campanella A
Clin Cancer Res; 2020 Dec; 26(23):6387-6398. PubMed ID: 32928793
[TBL] [Abstract][Full Text] [Related]
15. Metformin combined with quercetin synergistically repressed prostate cancer cells via inhibition of VEGF/PI3K/Akt signaling pathway.
Sun S; Gong F; Liu P; Miao Q
Gene; 2018 Jul; 664():50-57. PubMed ID: 29678660
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo anticancer effects of the novel vitamin E ether analogue RRR-alpha-tocopheryloxybutyl sulfonic acid in prostate cancer.
Ni J; Mai T; Pang ST; Haque I; Huang K; DiMaggio MA; Xie S; James NS; Kasi D; Chemler SR; Yeh S
Clin Cancer Res; 2009 Feb; 15(3):898-906. PubMed ID: 19188160
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of human tumour prostate PC-3 cell growth by cannabinoids R(+)-Methanandamide and JWH-015: involvement of CB2.
Olea-Herrero N; Vara D; Malagarie-Cazenave S; Díaz-Laviada I
Br J Cancer; 2009 Sep; 101(6):940-50. PubMed ID: 19690545
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the effects of androgenic Chinese herbal medicines on androgen receptors and tumor growth in experimental prostate cancer models.
Zhang ZB; Ip SP; Cho WC; Hu Z; Huang YF; Luo DD; Xian YF; Lin ZX
J Ethnopharmacol; 2020 Oct; 260():113058. PubMed ID: 32525068
[TBL] [Abstract][Full Text] [Related]
19. A novel bis-indole destabilizes microtubules and displays potent in vitro and in vivo antitumor activity in prostate cancer.
Ahn S; Hwang DJ; Barrett CM; Yang J; Duke CB; Miller DD; Dalton JT
Cancer Chemother Pharmacol; 2011 Feb; 67(2):293-304. PubMed ID: 20383708
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the anticancer and anti-metastasis effects of novel synthetic sodium channel blockers in prostate cancer cells in vitro and in vivo.
Wang J; Lu Z; Wu C; Li Y; Kong Y; Zhou R; Shi K; Guo J; Li N; Liu J; Song W; Wang H; Zhu M; Xu H
Prostate; 2019 Jan; 79(1):62-72. PubMed ID: 30242862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
